Yizheng Li - Bloomage Biotechnology Secretary GM

688363 Stock   50.12  0.18  0.36%   

Executive

Yizheng Li is Secretary GM of Bloomage Biotechnology Corp
Age 41
Address Tech Development Zone, Jinan, China, 250101
Phone86 531 8268 5998
Webhttps://www.bloomagebioactive.com

Bloomage Biotechnology Management Efficiency

The company has return on total asset (ROA) of 0.0319 % which means that it generated a profit of $0.0319 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.062 %, meaning that it generated $0.062 on every $100 dollars invested by stockholders. Bloomage Biotechnology's management efficiency ratios could be used to measure how well Bloomage Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At present, Bloomage Biotechnology's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 6.5 B, whereas Net Tangible Assets are forecasted to decline to about 3.4 B.

Similar Executives

Showing other executives

EXECUTIVE Age

Xingke YinAnhui Jianghuai Automobile
51
Hua ChenXiangyang Automobile Bearing
61
Peng ZhengAnhui Jianghuai Automobile
55
Weiya DongVanfund Urban Investment
N/A
Chen WangJiangsu Xinri E Vehicle
46
Zibin GuoVanfund Urban Investment
N/A
Rui ZhanCIMC Vehicles Co
44
Zhan YuanXiangyang Automobile Bearing
60
Meng TangLuyin Investment Group
38
Lai FanJiangsu Xinri E Vehicle
62
Zi PengXiangyang Automobile Bearing
60
Wai ACISCIMC Vehicles Co
48
Hao LuoAnhui Jianghuai Automobile
52
Yong XuJiangsu Xinri E Vehicle
59
Yong TangXiangyang Automobile Bearing
54
Meng JiaXiangyang Automobile Bearing
58
Wei YanXiangyang Automobile Bearing
59
Song HuaAnhui Jianghuai Automobile
48
Jie MengXiangyang Automobile Bearing
38
Delong WangAnhui Jianghuai Automobile
54
Guan WangXiangyang Automobile Bearing
59
Bloomage Biotechnology Corp (688363) is traded on Shanghai Stock Exchange in China and employs 4,655 people. Bloomage Biotechnology is listed under Specialty Chemicals category by Fama And French industry classification.

Management Performance

Bloomage Biotechnology Leadership Team

Elected by the shareholders, the Bloomage Biotechnology's board of directors comprises two types of representatives: Bloomage Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bloomage. The board's role is to monitor Bloomage Biotechnology's management team and ensure that shareholders' interests are well served. Bloomage Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bloomage Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lingli Lin, Deputy Director
Hui Wang, CFO Director
Guixin Xu, Deputy Manager
Gao Yi, Deputy Manager
Xueping Guo, Deputy Director
Aihua Wang, Ex Director
Yihong Luan, Deputy Technician
Yan Zhao, Chairman GM
Tao Tian, Head Supervisor
Luan Yizheng, Deputy Officer
Jiajun Guo, Deputy Director
Aihua Liu, Deputy Director
Yizheng Li, Secretary GM

Bloomage Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bloomage Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Bloomage Stock

Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.